Enhancement of learning behaviour by a potent nitric oxide-guanylate cyclase activator YC-1

被引:58
|
作者
Chien, WL
Liang, KC
Teng, CM
Kuo, SC
Lee, FY
Fu, WM
机构
[1] Natl Taiwan Univ, Coll Med, Inst Pharmacol, Taipei, Taiwan
[2] Natl Taiwan Univ, Dept Psychol, Taipei, Taiwan
[3] China Med Univ, Grad Inst Pharmaceut Chem, Taichung, Taiwan
关键词
cGMP; learning; long-term potentiation; memory; NO; PKG; YC-1;
D O I
10.1111/j.1460-9568.2005.03993.x
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Memory is one of the most fundamental mental processes, and various approaches have been used to understand the mechanisms underlying this process. Nitric oxide (NO), cGMP and protein kinase G (PKG) are involved in the modulation of synaptic plasticity in various brain regions. YC-1, which is a benzylindazole derivative, greatly potentiated the response of soluble guanylate cyclase to NO (up to several hundreds fold). We have previously shown that YC-1 markedly enhances long-term potentiation in hippocampal and amygdala slices via NO-cGMP-PKG-dependent pathway. We here further investigated whether YC-1 promotes learning behaviour in Morris water maze and avoidance tests. It was found that YC-1 shortened the escape latency in the task of water maze, increased and decreased the retention scores in passive and active avoidance task, respectively. Administration of YC-1 30 min after foot-shock stimulation did not significantly affect retention scores in response to passive avoidance test. Administration of scopolamine, a muscarinic antagonist, markedly impaired the memory acquisition. Pretreatment of YC-1 inhibited the scopolamine-induced learning deficit. The enhancement of learning behaviour by YC-1 was antagonized by intracerebroventricular injection of NOS inhibitor L-NAME and PKG inhibitors of KT5823 and Rp-8-Br-PET-cGMPS, indicating that NO-cGMP-PKG pathway is also involved in the learning enhancement action of YC-1. YC-1 is thus a good drug candidate for the improvement of learning and memory.
引用
收藏
页码:1679 / 1688
页数:10
相关论文
共 50 条
  • [21] The design and synthesis of YC-1 analogues as probes for soluble guanylate cyclase
    Hering, KW
    Artz, JD
    Pearson, WH
    Marletta, MA
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (03) : 618 - 621
  • [22] The nitric oxide independent activator of soluble guanylyl cyclase YC-1 improves nitrate tolerance in conduit arteries.
    Hink, U
    Molsch, A
    Heitzer, T
    Stasch, J
    Leverkusen, B
    Skatchkov, M
    von Sandersleben, A
    Munzel, T
    CIRCULATION, 1998, 98 (17) : 312 - 312
  • [23] Soluble guanylate cyclase: Effect of YC-1 on ligation kinetics with carbon monoxide
    Sharma, VS
    Magde, D
    Kharitonov, VG
    Koesling, D
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 254 (01) : 188 - 191
  • [24] Kinetics and equilibria of soluble guanylate cyclase ligation by CO: Effect of YC-1
    Kharitonov, VG
    Sharma, VS
    Magde, D
    Koesling, D
    BIOCHEMISTRY, 1999, 38 (33) : 10699 - 10706
  • [25] Synergistic activation of soluble guanylate cyclase by CO and YC-1: Effects of substrate
    Pal, B
    Li, ZQ
    Takenaka, S
    Tsuyama, S
    Kitagawa, T
    JOURNAL OF INORGANIC BIOCHEMISTRY, 2003, 96 (01) : 209 - 209
  • [26] Interaction of soluble guanylate cyclase with YC-1: Kinetic and resonance Raman studies
    Denninger, JW
    Schelvis, JPM
    Brandish, PE
    Zhao, Y
    Babcock, GT
    Marletta, MA
    BIOCHEMISTRY, 2000, 39 (14) : 4191 - 4198
  • [27] YC-1 induces structural changes in the heme pocket of soluble guanylate cyclase.
    Schelvis, JPM
    Denninger, JR
    Zhao, YD
    Brandish, PE
    Marletta, MA
    Babcock, GT
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1999, 217 : U1126 - U1126
  • [28] Conformational effects induced by YC-1 and carbon monoxide binding to soluble guanylate cyclase
    Lopez-Pena, Ignacio
    Kristianto, Jasmin
    Gerber, Nancy Counts
    Esquerra, Raymond
    FASEB JOURNAL, 2010, 24
  • [29] Computational exploration of the binding mode of the heme-dependent activator YC-1 into the active catalytic site of soluble guanylate cyclase
    Luis Agulló
    Ignasi Buch
    Hugo Gutiérrez de Terán
    Gianni de Fabritis
    David Garcia-Dorado
    Jordi Villà-Freixa
    BMC Pharmacology and Toxicology, 16 (Suppl 1)
  • [30] Effects of the soluble guanylyl cyclase activator YC-1 in piglet pulmonary arteries
    Villamor, E
    Gonzalez-Luis, G
    Moreno, L
    De Mey, JGR
    Blanco, CE
    Perez-Vizcaino, F
    PEDIATRIC RESEARCH, 2004, 55 (04) : 587A - 588A